Enhancing self-management of multimorbidity in primary care

Not Applicable

Completed

• Conditions: Multimorbidity; Not Applicable

• Registration Number: ISRCTN67235963
• Lead Sponsor: HRB Centre for Primary Care Research

Brief Summary

2015 Results article in http://www.ncbi.nlm.nih.gov/pubmed/25962515 results 2022 Results article in https://pubmed.ncbi.nlm.nih.gov/35137039/ Cost-effectiveness results (added 10/02/2022)

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2013-08-30
• Study Completion: 2018-09-07
• Last Update Posted: 21 February 2022

Recruitment & Eligibility

• Status: Completed
• Sex: All
• Target Recruitment: 149

Inclusion Criteria

Exploratory study:
1. Over 18 years of age, both male and female
2. Has a minimum of two chronic conditions
3. Has a minimum of four repeat medication
4. If a primary care clinician identifies they might benefit from the study

Follow-up study:
1. Multimorbidity, defined as two or more discrete conditions. This is the internationally accepted definition and encompasses a broad range of patients
2. Age > 40 years. This limit was chosen as multimorbidity is relatively uncommon in patients younger than this and it facilitates targeted recruitment. There is no upper age limit
3. Polypharmacy, defined as four or more repeat medications. This criterion was added in order to identify a group within the broader multimorbidity population that is at increased risk of poor health outcomes and therefore more likely to benefit from an intervention
4. Ability to attend a local community healthcare centre to participate in data collection and the intervention groups

Exclusion Criteria

Exploratory study:
1. If unable to travel to centre in which groups were held
2. If person had participated in the feasibility study (O'Toole, Connolly & Smith, 2013)

Follow-up study:
1. Psychiatric/psychological morbidity (such as psychosis) or cognitive impairment sufficient to impair participation in the intervention as confirmed by the individual’s GP and/ or practice nurse.
2. Terminal illness likely to lead to death or major disability during the study follow-up period.
3. Inability to attend intervention sessions held outside the home.
4. Participated in the previous pilot studies or exploratory trial.

Study & Design

• Study Type: Interventional
• Study Design: Not specified